View of Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review | Journal of Population Therapeutics and Clinical Pharmacology

Return to Article Details Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review